NovaCina Expands Perth Facility to Provide Clinical Supplies Services.
Exciting news from NovaCina! We’ve installed and qualified a new Cytiva SA25 GMP isolator filling line to support small- and medium-batch sizes for all clinical phases—vials, syringes and cartridges. Since acquiring the manufacturing plant from Pfizer in April 2023, we have invested heavily into the…
read more
WA Biotech Boom: Reliis and NovaCina’s Perfect Partnership
NovaCina is proud to collaborate with Reliis Limited, an emerging biotech company, in Western Australia’s dynamic life sciences sector. This partnership exemplifies the state’s entrepreneurial spirit, traditionally seen in the mining industry, now flourishing in new fields like BioTech and MedTech. Our collaboration with Reliis,…
read more
Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board
We are pleased to announce the appointment of John Van Der Wielen to our Board of Directors. His extensive accomplishments in corporate strategy across diverse industries, including the health industry, plus his proven track record of driving growth and innovation, makes him a valuable asset…
read more
Exciting News: NovaCina’s President, Brett Alderson, Featured on Molecule to Market Podcast!
We are thrilled to announce that our very own Brett Alderson, President and Site Leader of NovaCina, was recently featured on the Molecule to Market podcast hosted by Raman Sehgal. In this engaging episode, Brett delves into becoming a CDMO within the global drug development…
read more
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision
Mark W. Womack Named to Bridgewest Perth Pharma Pty Ltd Board of Directors (Miami and Perth, Australia, March 5, 2024) Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced today the appointment of Mark W. Womack as a…
read more
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma
–Industry veteran to lead growth for company’s CDMO and pharmaceutical supply divisions, NovaCina and LumaCina– MIAMI and PERTH, Australia, Oct. 24, 2023 /PRNewswire/ — Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today that Cyrus K. Mirsaidi is taking the worldwide helm…
read moreBridgewest Perth Pharma Recipient of Investment Attraction Fund
read more
UWA and Bridgewest Perth Pharma announce new partnership
read more
